« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 123, Issue 2
, Pages 328-332
, February 2009
Advances in basic and clinical immunology in 2008
References
- . Therapeutic approaches for control of transcription factors in allergic disease. J Allergy Clin Immunol. 2008;121:803–809
- . T-cell effector pathways in allergic diseases: transcriptional mechanism and therapeutic targets. J Allergy Clin Immunol. 2008;121:812–823
- . Targeting Fel d 1 to FcgRI induces a novel variant of the TH2 response in subjects with cat allergy. J Allergy Clin Immunol. 2008;121:756–762
- Immunosuppression of TH2 responses in Trichinella spiralis infection by Helicobacter pylori neutrophils-activating protein. J Allergy Clin Immunol. 2008;122:908–913
- . Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human b-defensin-3. J Allergy Clin Immunol. 2008;122:62–68
- . Increased activation-induced cell death of high IFN-gamma-producing Th1 cells as a mechanism of TH2 predominance in atopic diseases. J Allergy Clin Immunol. 2008;121:652–658
- Molecular and functional analysis of the antigen receptor of Art v 1-specific helper T lymphocytes. J Allergy Clin Immunol. 2008;121:64–71
- B cell receptor cross-linking delays activation-induced cytidine deaminase induction and inhibits class switch recombination. J Allergy Clin Immunol. 2008;121:191–196
- Epigallocatechin gallate affects human dendritic cell differentiation and maturation. J Allergy Clin Immunol. 2008;121:209–214
- Novel mouse mutants with primary cellular immunodeficiencies generated by genome-wide mutagenesis. J Allergy Clin Immunol. 2008;121:179–184
- Potential role of vasomotor effects of fibrinogen in bradykinin-induced angioedema. J Allergy Clin Immunol. 2008;121:969–975
- . Hereditary angioedema. J Allergy Clin Immunol. 2008;121:S398–S401
- Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P. J Allergy Clin Immunol. 2008;121:429–433
- . Viral reservoir, residual viremia and the potential of highly active retroviral therapy to eradicate HIV infection. J Allergy Clin Immunol. 2008;122:22–28
- Antiretroviral therapy corrects HIV-1-induced expansion of CD8+CD45RA+CD27-CD11abright activated T cell. J Allergy Clin Immunol. 2008;122:166–172
- increased incidence of asthma in HIV-infected children treated with highly active antiretroviral therapy in the National Institutes of Health Women and Infants Transmission Study. J Allergy Clin Immunol. 2008;122:159–165
- . Pathogenic mechanism of B-lymphocyte dysfunction in HIV disease. J Allergy Clin Immunol. 2008;122:12–19
- . Critical issues in mucosal immunity for HIV-1 vaccine development. J Allergy Clin Immunol. 2008;122:3–9
- . An age-dependent association of mannose-binding lectin-2 genetic variants on HIV1-related disease in children. J Allergy Clin Immunol. 2008;122:173–180
- Mannose-binding lectin and mannose-binding lectin associated serine protease 2 in susceptibility, severity, and outcome of pneumonia in adults. J Allergy Clin Immunol. 2008;122:368–374
- . Is it necessary to identify molecular defects in primary immunodeficiency disease?. J Allergy Clin Immunol. 2008;122:1069–1073
- Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced TH17 cell numbers, and variably defective STAT3 phosphorylation in hyper IgE syndrome. J Allergy Clin Immunol. 2008;122:181–187
- . Adenosine deaminase deficiency can present with features of Omenn syndrome. J Allergy Clin Immunol. 2008;121:1057–1058
- . Omenn syndrome is associated with mutations in DNA ligase IV. J Allergy Clin Immunol. 2008;122:1219–1220
- . Omenn syndrome- inflammation in leaky SCID. J Allergy Clin Immunol. 2008;122:1082–1086
- Simultaneous presentation of two primary immunodeficiencies: IL12 receptor beta 1 deficiency and ataxia telangiectasia. J Allergy Clin Immunol. 2008;122:1217–1219
- . The genetic heterogenecity of Mendelian susceptibility to mycobacterial diseases. J Allergy Clin Immunol. 2008;122:1043–1051
- Clinical and molecular profile of a new series of IPEX patients: inconsistent correlation between FOXP3 protein expression and disease severity. J Allergy Clin Immunol. 2008;122:1105–1112
- Variability of clinical and laboratory features among patients with ribonuclease mitochondrial RNA processing endoribonuclease gene mutations. J Allergy Clin Immunol. 2008;122:1178–1184
- Hypomorphic NEMO mutation database and reconstitution system identifies phenotypic and immunologic diversity. J Allergy Clin Immunol. 2008;122:1169–1177
- IKBKG (nuclear factor kB essential modulator) mutation can be associated with opportunistic infection without impairing Toll-like receptor function. J Allergy Clin Immunol. 2008;121:976–982
- Dysregulation of innate immune receptors on neutrophils in chronic granulomatous disease. J Allergy Clin Immunol. 2008;121:375–382
- Chronic granulomatous disease as a risk factor for autoimmune disease. J Allergy Clin Immunol. 2008;122:1097–1103
- Development of specific T cell responses to Candida and tetanus antigen in partial DiGeorge syndrome. J Allergy Clin Immunol. 2008;122:1194–1199
- . Immunologic defects in 22q11.2 deletion syndrome. J Allergy Clin Immunol. 2008;122:362–367
- . Immunoglobulin therapy—methods of delivery. J Allergy Clin Immunol. 2008;122:1038–1039
- . Biologic IgG level in primary immunodeficiency disease: the IgG level that protects against recurrent infection. J Allergy Clin Immunol. 2008;122:211–212
- . Consistency of protective antibody levels across lots of intravenous immunoglobulin preparations. J Allergy Clin Immunol. 2008;121:254–255
- Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb. J Allergy Clin Immunol. 2008;122:1185–1193
- Long term immune reconstitution after anti-CD52-treated or anti-CD34-treated hematopoietic stem cell transplantation for severe T-lymphocyte immunodeficiency. J Allergy Clin Immunol. 2008;121:361–367
- Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. J Allergy Clin Immunol. 2008;122:1087–1096
- . High-dose methylprednisolone is effective in the management of acute graft-versus-host disease in severe combined immune deficiency. J Allergy Clin Immunol. 2008;122:1215–1216
- Allogeneic transplantation successfully corrects immune defect, but not susceptibility to colitis, in a patient with NEMO deficiency. J Allergy Clin Immunol. 2008;122:1113–1118
Supported in part by National Institutes of Health grants AI069441, AI036211, HD052102, RR0188, HL079533, HL72705, HL78522, and RAT003084A; the Pediatric Research and Education Fund, Baylor College of Medicine; and the David Fund, Pediatrics AIDS Fund, and Immunology Research Fund, Texas Children's Hospital.
Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.
PII: S0091-6749(08)03536-7
doi: 10.1016/j.jaci.2008.12.1113
© 2009 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 123, Issue 2
, Pages 328-332
, February 2009
